Brentwood, TN, United States of America

Colleen M Niswender

USPTO Granted Patents = 20 

Average Co-Inventor Count = 7.0

ph-index = 9

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Colleen M. Niswender: Pioneering Innovations in Neurological Treatments

Introduction: Colleen M. Niswender, based in Brentwood, Tennessee, is a distinguished inventor in the field of pharmaceuticals with a focus on neurological dysfunction. With a remarkable portfolio of 19 patents, her work is essential in advancing therapeutic options for conditions related to glutamate dysfunction.

Latest Patents: Among her latest patents are groundbreaking contributions to medical science. Her inventions include indazole compounds that serve as allosteric potentiators for the metabotropic glutamate receptor subtype 4 (mGluR4). These compounds have significant potential for treating neurological and psychiatric disorders. Similarly, her patent on pyridine quinoline compounds as mGluR4 allosteric potentiators offers synthetic methods and pharmaceutical compositions that aim to improve treatments for diseases associated with glutamate dysfunction.

Career Highlights: Colleen M. Niswender's career is marked by her innovative research at Vanderbilt University. Her continuous pursuit of knowledge and application in pharmaceutical sciences reflects her commitment to developing effective treatments for complex neurological conditions. The insights gained from her research are invaluable, making a tangible impact on the field.

Collaborations: Throughout her career, Colleen has collaborated with other esteemed researchers, including P. Jeffrey Conn and Craig William Lindsley. These partnerships have led to significant advancements in understanding and addressing neurological disorders, highlighting the importance of teamwork in the scientific community.

Conclusion: Colleen M. Niswender continues to be a pivotal figure in pharmaceutical innovation, particularly in her work related to neurological dysfunction. Her extensive patent portfolio signifies a deep commitment to enhancing therapeutic options for patients suffering from various psychological and neurological disorders. As her research progresses, the scientific community eagerly anticipates the future implications of her groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…